Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
House OKs bill to permit IRB‑approved cannabis research, sponsors say 'cautious first step'
Summary
First substitute HB130 cleared the Utah House to let licensed IRBs approve cannabis‑based clinical studies and distinguish research products from in‑state production rules; sponsors called it a cautious, necessary step to gather data. Vote: 70–2.
The Utah House passed first substitute House Bill 130 on Feb. 7, 2017, a measure designed to permit institutional review board (IRB)‑approved studies of cannabinoid products while imposing licensing and federal‑compliance requirements for import or handling of Schedule I substances.
Representative (sponsor) said the bill seeks to let scientific institutions test cannabis products’ benefits and risks under established federal IRB procedures, rather than allowing legislators to declare therapeutic uses. “We’ll let them play doctor,” the sponsor said, describing…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
